Fundz

Pulse Biosciences Appoints Paul A. LaViolette as Chief Executive Officer

PUBLIC · PLSEJan 10, 2025

Position

Chief Executive Officer

Company

Pulse Biosciences, Inc.

Paul A. LaViolette
paul.laviolette@pulsebiosciences.com
HaywardBiotechnologyHealth CareMedicalTherapeutics

Description

Pulse Biosciences announced the appointment of Paul A. LaViolette, the current Co-Chairman of the Board, as the Chief Executive Officer. The company is excited to have Paul lead and contribute to its continued success.

Quick answer

Pulse Biosciences Appoints Paul A. LaViolette as Chief Executive Officer (January 10, 2025). Pulse Biosciences, Inc. is based in Hayward, California, United States.

Who is the new Chief Executive Officer at Pulse Biosciences, Inc?
Pulse Biosciences, Inc. named Paul A. LaViolette Chief Executive Officer, announced January 10, 2025.
What did Pulse Biosciences, Inc. announce on January 10, 2025?
Pulse Biosciences announced the appointment of Paul A. LaViolette, the current Co-Chairman of the Board, as the Chief Executive Officer. The company is excited to have Paul lead and contribute to its continued success.
What does Pulse Biosciences, Inc. do?
Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology.
Where is Pulse Biosciences, Inc. based?
Pulse Biosciences, Inc. is based in Hayward, California, United States.
Which similar companies made leadership changes around the same time?
Actimed Therapeutics (January 16, 2025), Pliant Therapeutics (January 22, 2025), NYU Langone Health (December 20, 2024) and On Target Laboratories (December 10, 2024) also announced leadership changes within 45 days of Pulse Biosciences, Inc.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Pulse Biosciences, Inc., and when

A new leader at Pulse Biosciences, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Pulse Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pulse Biosciences, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pulse Biosciences, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pulse Biosciences, Inc.

Location

3957 POINT EDEN WAY

Hayward, California, United States

About

Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology. We are committed to health innovation that has the potential to improve and extend the lives of patients. Our proprietary Nanosecond Pulsed Field Ablation technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pulse Biosciences, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Kevin
Likely contact at this company
••••••••@••••••••

See Kevin's verified email →

John
Senior decision-maker at this company
••••••••@••••••••

See John's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Pulse Biosciences, Inc.'s next move

Learn about Strategic plan

Pulse Biosciences, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.